OXYCODONE HCl CR TABLETS 10 mg 100s CII
NDC: 00591-3501-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE HCl CR TABLETS 20 mg 100s CII
NDC: 00591-3502-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE HCl CR TABLETS 40 mg 100s CII
NDC: 00591-3503-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE HCl CR TABLETS 80 mg 100s CII
NDC: 00591-3504-01
*Compare to: Oxycontin®, a registered trademark of Purdue

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE/APAP TABLETS 5/325 mg 100s CII
NDC: 00591-0749-01
*Compare to: Percocet®, a registered trademark of Endo Laboratories

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE/APAP TABLETS 7.5/325 mg 100s CII
NDC: 00591-0933-01
*Compare to: Percocet®, a registered trademark of Endo Laboratories

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE/APAP TABLETS 7.5/500 mg 100s CII
NDC: 00591-0824-01
*Compare to: Percocet®, a registered trademark of Endo Laboratories

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE/APAP TABLETS 10/325 mg 100s CII
NDC: 00591-0932-01
*Compare to: Percocet®, a registered trademark of Endo Laboratories

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE/APAP TABLETS 10/650 mg 100s CII
NDC: 00591-0825-01
*Compare to: Percocet®, a registered trademark of Endo Laboratories

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE/APAP CAPSULES 5/500 mg 100s CII
NDC: 00591-0737-01
*Compare to: Tylox®, a registered trademark of Ortho-McNeil

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

OXYCODONE/ASP TABLETS 4.5/0.38/325 mg 100s CII
NDC: 00591-0820-01
*Compare to: Percodan®, a registered trademark of Endo Laboratories

*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.

 

INDICATIONS AND USAGE

Oxycodone and acetaminophen tablets are indicated for the relief of moderate to moderately severe pain.

 

INFORMATION FOR PATIENTS

Oxycodone may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. The patient using oxycodone and acetaminophen tablets should be cautioned accordingly.

The following information should be provided to patients receiving oxycodone and aspirin tablets by their physician, nurse, pharmacist, or caregiver:

  1. Patients should be aware that oxycodone and aspirin tablets contain oxycodone, which is a morphine-like substance.

  2. Patients should be instructed to keep oxycodone and aspirin tablets in a secure place out of the reach of children. In the case of accidental ingestions, emergency medical care should be sought immediately.

  3. When oxycodone and aspirin tablets are no longer needed, the unused tablets should be destroyed by flushing down the toilet.

  4. Patients should be advised not to adjust the medication dose themselves. Instead, they must consult with their prescribing physician.

  5. Patients should be advised that oxycodone and aspirin tablets may impair mental and/or physical ability required for the performance of potentially hazardous tasks (e.g., driving, operating heavy machinery).

  6. Patients should not combine oxycodone and aspirin tablets with alcohol, opioid analgesics, tranquilizers, sedatives, or other CNS depressants unless under the recommendation and guidance of a physician. When co-administered with another CNS depressant, oxycodone and aspirin tablets can cause dangerous additive central nervous system or respiratory depression, which can result in serious injury or death.

  7. The safe use of oxycodone and aspirin tablets during pregnancy has not been established; thus, women who are planning to become pregnant or are pregnant should consult with their physician before taking oxycodone and aspirin tablets.

  8. Nursing mothers should consult with their physicians about whether to discontinue nursing or discontinue oxycodone and aspirin tablets because of the potential for serious adverse reactions to nursing infants.

  9. Patients who are treated with oxycodone and aspirin tablets for more than a few weeks should be advised not to abruptly discontinue the medication. Patients should consult with their physician for a gradual discontinuation dose schedule to taper off the medication.

  10. Patients should be advised that oxycodone and aspirin tablets are a potential drug of abuse. They should protect it from theft, and it should never be given to anyone other than the individual for whom it was prescribed.